In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
- TRADE NAMES: Dolophine (Roxane); Eptadone; L-Polamidon; Mephenon; Metadon; Methadose (Mallinckrodt)
- INDICATIONS: Pain, narcotic addiction
- CLASS: Opiate agonist
- HALF-LIFE: 15–25 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Abacavir, Amprenavir, Boceprevir, Citalopram, Darunavir, Delavirdine, Diazepam, Efavirenz, Erythromycin, Fluconazole, Fluvoxamine, Interferon Alfa, Itraconazole, Ketoconazole, Linezolid, Lofexidine, Lopinavir, Nelfinavir, Nilotinib, Paroxetine Hydrochloride, PEG-Interferon, Quetiapine, Ribociclib, Rifapentine, Rilpivirine, Safinamide, Selegiline, St John's Wort, Tipranavir, Vandetanib, Voriconazole, Zidovudine, Zuclopenthixol
- See adverse reactions attributed to class:
Methadone is not licensed for use in children though it can be employed for the management of neonatal opiate withdrawal syndrome
Please login to view the rest of this drug profile.
Page last updated 05/08/2024
